VIR BIOTECHNOLOGY, I

VIR
Delayed Quote. Delayed  - 10/18 04:00:00 pm
38.8USD -0.74%

Turn to zoom
Prev.39.0900
Open38.7900
High39.4700
Low38.4650
Volume570 128
Latest news
3d ago
3d ago
7d ago
10/08
Chart VIR BIOTECHNOLOGY, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishNeutral
Resistance43,543,576,6
Spread/Res.-11%-11%-49%
Spread/Supp.16%16%45%
Support33,533,526,8
Financials
Sales 2021 450 M - -
Net income 2021 -97,0 M - -
Net cash 2021 667 M - -
P/E ratio 2021 -51,5x
Yield 2021 -
Capitalization 5 068 M 5 068 M -
EV / Sales 2021 9,77x
EV / Sales 2022 10,0x
Nbr of Employees 367
Free-Float 86,9%
Company
Vir Biotechnology, Inc. is a clinical-stage immunology company focused on treating and preventing serious infectious diseases. It has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid (siRNA), through internal development,...

>> Read more
Sector :
Other Biotechnology & Medical Research
Calendar :
2021-11-12 Presentation
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 38,80 $
Average target price 68,14 $
Spread / Average Target 75,6%